Suchergebnisse - "Otten, Antonius T"

PubPharm (15)

1

Interleukin-18 Inhibition in Inflammatory Bowel Disease : A Delicate Balance

enthalten in: Inflammatory bowel diseases | 2024

von Geertsema, S. | Fagundes, R. | Otten, A. | +3

CommentOn: Inflamm Bowel Dis. 2023 Dec 23;:. - PMID 38141180

2

Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease

enthalten in: Inflammatory bowel diseases | 2024

von Otten, A. | van der Meulen, H. | Steenhuis, M. | +8

CommentIn: Inflamm Bowel Dis. 2024 Feb 1;30(2):316-317. - PMID 37632440

3

The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease : An Emphasis on the Essential Ingredients

enthalten in: Inflammatory bowel diseases | 2024

von Otten, A. | Dijkstra, G. | Visschedijk, M. | +1

CommentIn: Inflamm Bowel Dis. 2023 Aug 26;:. - PMID 37632440

4

The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases : Do Immunosuppressive Drugs Matter?

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Bourgonje, A. | Otten, A.

CommentOn: Clin Gastroenterol Hepatol. 2022 Jul;20(7):1570-1578.e1. - PMID 34274513

5

Temporary diverting stoma in therapy-refractory luminal colonic Crohn's disease : an alternative to immediate colorectal resection?

enthalten in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland | 2023

von van der Holst, A. | Otten, A. | Praag, E. | +6

6

Capsules with Ileocolonic-Targeted Release of Vitamin B2, B3, and C (ColoVit) Intended for Optimization of Gut Health : Development and Validation of the Production Process

enthalten in: Pharmaceutics | 2023

von Ahmed, A. | Otten, A. | Gareb, B. | +7

7

Assessment of Fecal Glycosylated Mucins as Novel Biomarkers in Inflammatory Bowel Diseases

enthalten in: Inflammatory bowel diseases | 2023

von Geertsema, S. | Otten, A. | Bouwknegt, D. | +2

CommentOn: Inflamm Bowel Dis. 2023 Jan 5;29(1):167-171. - PMID 36426845

8

Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Otten, A. | Bourgonje, A. | Visschedijk, M.

CommentOn: Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156. - PMID 36481043

9

Temporary diverting stoma in therapy‐refractory luminal colonic Crohn's disease : an alternative to immediate colorectal resection?

enthalten in: Colorectal Disease | 2023

von Holst, A. | Otten, A. | Praag, E. | +6

10

The effect of riboflavin supplementation on the systemic redox status in healthy volunteers : A post-hoc analysis of the RIBOGUT trial

enthalten in: Free radical biology & medicine | 2022

von Bourgonje, A. | Otten, A. | Sadaghian Sadabad, M. | +6